FluGen flugen.com


Public list: BIO 2016 (619) Pharma Startups (4732)

FluGen is developing a universal influenza vaccine. The REDEE FLU influenza vaccine contains mutations in the M2 gene of the virus. The mutated virus can infect cells, express the entire spectrum of influenza RNA and proteins, yet fails to produce any infectious virus particles. Thus, the vaccine does not shed infectious virus and does not cause any pathological signs of infection. In multiple animal models, REDEE FLU is safe yet induces robust innate, antibody and cellular immune responses that...Show all

FluGen is developing a universal influenza vaccine. The REDEE FLU influenza vaccine contains mutations in the M2 gene of the virus. The mutated virus can infect cells, express the entire spectrum of influenza RNA and proteins, yet fails to produce an...Show all

Company (Alive / Active)

Phone: 608-441-2729

Fax:

597 Science Drive

Madison, 53711
Wisconsin, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
FluGen $29.6M Nov 13, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related FluGen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Venture InvestorsVenture CapitalMadison, Wisconsin, United StatesSeries A
State of Wisconsin Investment BoardGovernmentMadison, Wisconsin, United StatesSeries A
MGE Innovation CenterIncubator/AcceleratorMadison, Wisconsin, United StatesIncubator/Accelerator
Undisclosed InvestorsOtherDebt - III, Debt - II, Debt, Unattributed
KnoxOtherSeries A
See all 7 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Influenza virus mutants and uses therefor Feb 10, 2016 Mar 20, 2018 Patent
Influenza virus mutants and uses therefor Feb 10, 2016 Mar 20, 2018 Patent
Influenza virus vectors and uses therefor Mar 13, 2015 Sep 12, 2017 Patent
Influenza virus mutants and uses therefor Jun 21, 2012 Mar 15, 2016 Patent
Wearable drug delivery device having spring drive and sliding actuation mechanism Nov 03, 2011 Mar 11, 2014 Patent
See all 10 patents